Log In
Wednesday 21st March 2018

Aspirin users warning

1st September 2009

A trial has found that the use of aspirin in order to prevent heart attacks by people who do not have heart problems "cannot be supported".


The findings of the Aspirin for Asymptomatic Atherosclerosis (AAA) trial stand in contrast to the popular belief that taking aspirin every day will help people to avoid cardiovascular problems.

The trial, which was partly funded by the British Heart Foundation (BHF), involved 28,980 male and female participants aged 50 to 75 years in central Scotland, who did not have "clinically evident" cardiovascular disease.

Professor Peter Weissberg of the BHF said: "We know that patients with symptoms of artery disease, such as angina, heart attack or stroke, can reduce their risk of further problems by taking a small dose of aspirin each day."

"The findings of this study agree with our current advice that people who do not have symptomatic or diagnosed artery or heart disease should not take aspirin, because the risks of bleeding may outweigh the benefits."

The trial was headed by Professor Gerry Fowkes from the Wolfson Unit for Prevention of Peripheral Vascular Diseases in Edinburgh and the results were shared in a presentation at the European Society of Cardiology Congress in Barcelona.

A previous study published in The Lancet stated that aspirin should not be taken in a routine manner for the prevention of cardiovascular problems or stroke.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018